A novel microRNA miR-1165-3p as a potential diagnostic biomarker for allergic asthma

Abstract

Context: A further examination of a novel miRNA,miR-1165-3p as a biomarker for asthma, which was previously implicated in helper T cells (Th2) in a murine asthma model.

Objective: To determine whether serum miR-1165-3p can serve as a potential diagnostic biomarker for allergic asthma.

Methods: Serum miR-1165-3p was quantified via quantitative real-time PCR (qRT-PCR) in asthmatic and control samples. Serum miR-1165-3p levels were compared between groups and the clinical diagnostic abilities of miR-1165-3p were evaluated. The analyses utilized included a student’s t test, one-way ANOVA, and the generation of receiver operating characteristic (ROC) curves.

Results: Serum miRNA-1165-3p levels were significantly elevated in asthmatics when compared to the healthy controls. Furthermore, the sensitivity and specificity of serum miR-1165-3p were found to be 83% and 68.2%. Additionally, serum miR-1165-3p levels were also found to be significantly elevated in patients with allergic rhinitis (AR) or allergic bronchopulmonary aspergillosis (ABPA).

Conclusions: This study showed that serum miR-1165-3p can potentially be utilized as a noninvasive biomarker that is able to aid in the diagnosis and characterization of allergic asthma.

Keywords:

• Asthma
• miR-1165-3p
• allergic rhinitis (AR)
• allergic bronchopulmonary aspergillums (ABPA)
• biomarker
• Th2

Acknowledgments

We would like to thank LetPub (www.letpub.com) for providing linguistic assistance during the preparation of this manuscript.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the National Natural Science Foundation of China 81770031, 81700028, the Natural Science Foundation of Jiangsu Province BK20171501, SBK2017080, BK20181497, Precision Medicine Research of the National Key Research and Development Plan of China (2016YFC0905800), Jiangsu Province’s Young Medical Talent Program, China (QNRC2016600) and Jiangsu Provincial Health and Family Planning Commission Foundation (Q2017001), the ‘Six Talent Peak’ Project of Jiangsu Province (2013-WSN-059), the administration of the Traditional Chinese Medicine of Jiangsu Province (LZ13213), the Jiangsu Provincial Commission of Health and Family Planning (H201501), and Jiangsu Provincial Postgraduate Training Innovation Program (SJLX16_0373).